Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Acta Academiae Medicinae Sinicae ; (6): 670-674, 2006.
Article in Chinese | WPRIM | ID: wpr-313709

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of short hairpin RNA (shRNA) targeting hypoxia-inducible factor-1 alpha (HIF-1 alpha) on the human breast carcinoma MCF-7 cell line.</p><p><b>METHODS</b>The hypoxia environment was achieved by treating cells with cobalt chloride. The shRNA eukaryotic expression vector targeting HIF-1 alpha was constructed, and transfected into MCF-7 cells through lipofectamine 2000. Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to study the expression of vascular endothelial growth factor (VEGF). The mRNA and protein level of HIF-1 alpha were detected by real-time PCR and Western blot. Sub-G1 apoptotic population analysis, Annexin V/PI binding assay, and DNA ladder analysis were applied to investigate the cell apoptosis. The cell cycle was detected by flow cytometry.</p><p><b>RESULTS</b>The mRNA and protein level of HIF-1 alpha increased after exposure of MCF-7 cells to hypoxia (P < 0.01). However, apoptosis was lower in hypoxia compared with normoxia (P < 0.05). The HIF-1 level of MCF-7 transfected with HIF-1 alpha shRNA decreased approximately 91.63% (P < 0.01). When the cells were treated with or without apoptosis inducer Ara-C, the apoptosis of MCF-7 cells transfected with HIF-1 alpha shRNA increased by 1.75 times (P < 0.01) and 61. 31 times (P < 0.01), respectively. The expression of VEGF in MCF-7 cells transfected with HIF-1 alpha shRNA decreased 66.8% compared with untransfected cells (P < 0.05). Cell cycle progression was inhibited when the MCF-7 cells were transfected with HIF-1 alpha shRNA.</p><p><b>CONCLUSIONS</b>HIF-1 alpha plays an anti-apoptotic role in human breast carcinoma MCF-7 cell line. The shRNA we designed targeting HIF-1 alpha in MCF-7 can promote cell apoptosis, inhibit the expression of VEGF, and delay cell cycle progression.</p>


Subject(s)
Female , Humans , Apoptosis , Breast Neoplasms , Genetics , Metabolism , Pathology , Cell Cycle , Cell Line, Tumor , Down-Regulation , Hypoxia-Inducible Factor 1, alpha Subunit , Genetics , RNA Interference , RNA, Messenger , Genetics , RNA, Small Interfering , Genetics , Transfection , Vascular Endothelial Growth Factor A , Metabolism
2.
Acta Academiae Medicinae Sinicae ; (6): 364-367, 2006.
Article in Chinese | WPRIM | ID: wpr-281197

ABSTRACT

<p><b>OBJECTIVE</b>To explore the effect of hemangiopoietin (HAPO) on the adhesive properties of human umbilical vein endothelial cells (HUVEC).</p><p><b>METHODS</b>The adhesion of HUVEC and the expressions of CD54, CD102, CD106, CD31, CD62E, and CD62P were measured by adhesion assay, flow cytometry, and semi-quantitative RT-PCR.</p><p><b>RESULTS</b>HAPO enhanced the total adherence of HUVEC in a concentration-dependent manner. Flow cytometry analysis revealed that the treatment of HAPO resulted in a significantly increased expression of CD106 and CD62E on HUVEC in a time-dependent manner. When HUVEC were incubated with HAPO for 6 h, the percentage of CD106 + HUVEC and CD62E HUVEC increased about 2.10 folds and 5.84 folds, respectively, compared with control. The time-course of adhesive molecules mRNA expression indicated that the expression of CD106 and CD62E reached at the maximum 1.86 folds and 6.16 folds, respectively, compared with control.</p><p><b>CONCLUSION</b>HAPO may facilitate the homing of hematopoietic stem/progenitor cells.</p>


Subject(s)
Humans , Cell Adhesion Molecules , Metabolism , Cells, Cultured , E-Selectin , Genetics , Endothelial Cells , Cell Biology , Intercellular Adhesion Molecule-1 , Genetics , Proteoglycans , Pharmacology , RNA, Messenger , Genetics , Umbilical Veins , Cell Biology , Vascular Cell Adhesion Molecule-1 , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL